Loading…
Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells
Recent studies have indicated the importance of cholesterol-rich membrane lipid rafts (LRs) in oxidative stress-induced signal transduction. Reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases, the major sources of reactive oxygen species, are implicated in cardiovascular diseases,...
Saved in:
Published in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 2008-02, Vol.51 (2, Part 2), p.481-487 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c6081-7b34beeb0a9beb54b8a48406129f7c8dabc2daa4043fd30ed55ff087662d54fa3 |
---|---|
cites | cdi_FETCH-LOGICAL-c6081-7b34beeb0a9beb54b8a48406129f7c8dabc2daa4043fd30ed55ff087662d54fa3 |
container_end_page | 487 |
container_issue | 2, Part 2 |
container_start_page | 481 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 51 |
creator | Han, Weixing Li, Hewang Villar, Van Anthony M Pascua, Annabelle M Dajani, Mustafa I Wang, Xiaoyang Natarajan, Aruna Quinn, Mark T Felder, Robin A Jose, Pedro A Yu, Peiying |
description | Recent studies have indicated the importance of cholesterol-rich membrane lipid rafts (LRs) in oxidative stress-induced signal transduction. Reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases, the major sources of reactive oxygen species, are implicated in cardiovascular diseases, including hypertension. We tested the hypothesis that NADPH oxidase subunits and activity are regulated by LRs in human renal proximal tubule cells. We report that a high proportion of p22 and the small GTPase Rac1 are expressed in LRs in human renal proximal tubule cells. The D1-like receptor agonist, fenoldopam (1 μmol/L per 20 minutes) dispersed Nox subunits within LRs and non-LRs and decreased oxidase activity (30.7±3.3%). In contrast, cholesterol depletion (2% methyl-β-cyclodextrin [βCD]) translocated NADPH oxidase subunits out of LRs and increased oxidase activity (154.0±10.5% versus control, 103.1±3.4%), which was reversed by cholesterol repletion (118.9±9.9%). Moreover, NADPH oxidase activation by βCD (145.5±9.0%; control98.6±1.6%) was also abrogated by the NADPH oxidase inhibitors apocynin (100.4±3.2%) and diphenylene iodonium (9.5±3.3%). Furthermore, βCD-induced reactive oxygen species production was reversed by knocking down either Nox2 (81.0±5.1% versus βCD162.0±2.0%) or Nox4 (108.0±10.8% versus βCD152.0±9.8%). We have demonstrated for the first time that disruption of LRs results in NADPH oxidase activation that is abolished by antioxidants and silencing of Nox2 or Nox4. Therefore, in human renal proximal tubule cells, LRs maintain NADPH oxidase in an inactive state. |
doi_str_mv | 10.1161/HYPERTENSIONAHA.107.103275 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70237154</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70237154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6081-7b34beeb0a9beb54b8a48406129f7c8dabc2daa4043fd30ed55ff087662d54fa3</originalsourceid><addsrcrecordid>eNpdkF9v0zAUxS0EYmXwFZCFxN4yfP0nTnirSiHVqrbqisSeLDu5VgNpUuJkG98es1YgYcm-1tHv3nt0CHkH7BoghQ_F3Wa-3c1Xt4v1alpMr4HpeAXX6hmZgOIykSoVz8mEQS6THODbBXkVwnfGQEqpX5ILyCBXoPIJuVvWx7qiW-uHQG8Qj3Q1_bQp6PqxrmxAWrd02CNdtLYc6nukt4MdntRiPNiWbrG1Dd303WN9iJ_d6MYG6QybJrwmL7xtAr4510vy9fN8NyuS5frLYjZdJmXKMki0E9IhOmZzh05Jl1mZSZYCz70us8q6klfWSiaFrwTDSinvWabTlFdKeisuydVp7rHvfo4YBnOoQxkd2Ba7MRjNuNCgZAQ_nsCy70Lo0ZtjH133vwww8ydY81-wUdfmFGxsfnveMroDVv9az0lG4P0ZsKG0je9tW9bhL8cZjzaUiJw8cQ9dM2AffjTjA_Zmj7YZ9obFI3maJZyxjMUHkqgAiN9hNJHj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70237154</pqid></control><display><type>article</type><title>Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells</title><source>EZB Free E-Journals</source><creator>Han, Weixing ; Li, Hewang ; Villar, Van Anthony M ; Pascua, Annabelle M ; Dajani, Mustafa I ; Wang, Xiaoyang ; Natarajan, Aruna ; Quinn, Mark T ; Felder, Robin A ; Jose, Pedro A ; Yu, Peiying</creator><creatorcontrib>Han, Weixing ; Li, Hewang ; Villar, Van Anthony M ; Pascua, Annabelle M ; Dajani, Mustafa I ; Wang, Xiaoyang ; Natarajan, Aruna ; Quinn, Mark T ; Felder, Robin A ; Jose, Pedro A ; Yu, Peiying</creatorcontrib><description>Recent studies have indicated the importance of cholesterol-rich membrane lipid rafts (LRs) in oxidative stress-induced signal transduction. Reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases, the major sources of reactive oxygen species, are implicated in cardiovascular diseases, including hypertension. We tested the hypothesis that NADPH oxidase subunits and activity are regulated by LRs in human renal proximal tubule cells. We report that a high proportion of p22 and the small GTPase Rac1 are expressed in LRs in human renal proximal tubule cells. The D1-like receptor agonist, fenoldopam (1 μmol/L per 20 minutes) dispersed Nox subunits within LRs and non-LRs and decreased oxidase activity (30.7±3.3%). In contrast, cholesterol depletion (2% methyl-β-cyclodextrin [βCD]) translocated NADPH oxidase subunits out of LRs and increased oxidase activity (154.0±10.5% versus control, 103.1±3.4%), which was reversed by cholesterol repletion (118.9±9.9%). Moreover, NADPH oxidase activation by βCD (145.5±9.0%; control98.6±1.6%) was also abrogated by the NADPH oxidase inhibitors apocynin (100.4±3.2%) and diphenylene iodonium (9.5±3.3%). Furthermore, βCD-induced reactive oxygen species production was reversed by knocking down either Nox2 (81.0±5.1% versus βCD162.0±2.0%) or Nox4 (108.0±10.8% versus βCD152.0±9.8%). We have demonstrated for the first time that disruption of LRs results in NADPH oxidase activation that is abolished by antioxidants and silencing of Nox2 or Nox4. Therefore, in human renal proximal tubule cells, LRs maintain NADPH oxidase in an inactive state.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.107.103275</identifier><identifier>PMID: 18195159</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Acetophenones - pharmacology ; Arterial hypertension. Arterial hypotension ; beta-Cyclodextrins - pharmacology ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood vessels and receptors ; Cardiology. Vascular system ; Cell Membrane - enzymology ; Cholesterol - metabolism ; Dopamine Agonists - pharmacology ; Enzyme Activation - drug effects ; Enzyme Inhibitors - pharmacology ; Fenoldopam - pharmacology ; Fundamental and applied biological sciences. Psychology ; Humans ; Immunoblotting ; Isoenzymes - genetics ; Kidney Tubules, Proximal - cytology ; Kidney Tubules, Proximal - enzymology ; Medical sciences ; Membrane Glycoproteins - antagonists & inhibitors ; Membrane Glycoproteins - genetics ; Membrane Microdomains - physiology ; NADPH Oxidase 2 ; NADPH Oxidase 4 ; NADPH Oxidases - antagonists & inhibitors ; NADPH Oxidases - genetics ; NADPH Oxidases - metabolism ; Onium Compounds - pharmacology ; Reactive Oxygen Species - metabolism ; Receptors, Dopamine D1 - agonists ; RNA, Messenger - metabolism ; RNA, Small Interfering - pharmacology ; Vertebrates: cardiovascular system</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2008-02, Vol.51 (2, Part 2), p.481-487</ispartof><rights>2008 American Heart Association, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6081-7b34beeb0a9beb54b8a48406129f7c8dabc2daa4043fd30ed55ff087662d54fa3</citedby><cites>FETCH-LOGICAL-c6081-7b34beeb0a9beb54b8a48406129f7c8dabc2daa4043fd30ed55ff087662d54fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20223753$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18195159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Weixing</creatorcontrib><creatorcontrib>Li, Hewang</creatorcontrib><creatorcontrib>Villar, Van Anthony M</creatorcontrib><creatorcontrib>Pascua, Annabelle M</creatorcontrib><creatorcontrib>Dajani, Mustafa I</creatorcontrib><creatorcontrib>Wang, Xiaoyang</creatorcontrib><creatorcontrib>Natarajan, Aruna</creatorcontrib><creatorcontrib>Quinn, Mark T</creatorcontrib><creatorcontrib>Felder, Robin A</creatorcontrib><creatorcontrib>Jose, Pedro A</creatorcontrib><creatorcontrib>Yu, Peiying</creatorcontrib><title>Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Recent studies have indicated the importance of cholesterol-rich membrane lipid rafts (LRs) in oxidative stress-induced signal transduction. Reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases, the major sources of reactive oxygen species, are implicated in cardiovascular diseases, including hypertension. We tested the hypothesis that NADPH oxidase subunits and activity are regulated by LRs in human renal proximal tubule cells. We report that a high proportion of p22 and the small GTPase Rac1 are expressed in LRs in human renal proximal tubule cells. The D1-like receptor agonist, fenoldopam (1 μmol/L per 20 minutes) dispersed Nox subunits within LRs and non-LRs and decreased oxidase activity (30.7±3.3%). In contrast, cholesterol depletion (2% methyl-β-cyclodextrin [βCD]) translocated NADPH oxidase subunits out of LRs and increased oxidase activity (154.0±10.5% versus control, 103.1±3.4%), which was reversed by cholesterol repletion (118.9±9.9%). Moreover, NADPH oxidase activation by βCD (145.5±9.0%; control98.6±1.6%) was also abrogated by the NADPH oxidase inhibitors apocynin (100.4±3.2%) and diphenylene iodonium (9.5±3.3%). Furthermore, βCD-induced reactive oxygen species production was reversed by knocking down either Nox2 (81.0±5.1% versus βCD162.0±2.0%) or Nox4 (108.0±10.8% versus βCD152.0±9.8%). We have demonstrated for the first time that disruption of LRs results in NADPH oxidase activation that is abolished by antioxidants and silencing of Nox2 or Nox4. Therefore, in human renal proximal tubule cells, LRs maintain NADPH oxidase in an inactive state.</description><subject>Acetophenones - pharmacology</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>beta-Cyclodextrins - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood vessels and receptors</subject><subject>Cardiology. Vascular system</subject><subject>Cell Membrane - enzymology</subject><subject>Cholesterol - metabolism</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Fenoldopam - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Immunoblotting</subject><subject>Isoenzymes - genetics</subject><subject>Kidney Tubules, Proximal - cytology</subject><subject>Kidney Tubules, Proximal - enzymology</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - antagonists & inhibitors</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Microdomains - physiology</subject><subject>NADPH Oxidase 2</subject><subject>NADPH Oxidase 4</subject><subject>NADPH Oxidases - antagonists & inhibitors</subject><subject>NADPH Oxidases - genetics</subject><subject>NADPH Oxidases - metabolism</subject><subject>Onium Compounds - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Receptors, Dopamine D1 - agonists</subject><subject>RNA, Messenger - metabolism</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>Vertebrates: cardiovascular system</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpdkF9v0zAUxS0EYmXwFZCFxN4yfP0nTnirSiHVqrbqisSeLDu5VgNpUuJkG98es1YgYcm-1tHv3nt0CHkH7BoghQ_F3Wa-3c1Xt4v1alpMr4HpeAXX6hmZgOIykSoVz8mEQS6THODbBXkVwnfGQEqpX5ILyCBXoPIJuVvWx7qiW-uHQG8Qj3Q1_bQp6PqxrmxAWrd02CNdtLYc6nukt4MdntRiPNiWbrG1Dd303WN9iJ_d6MYG6QybJrwmL7xtAr4510vy9fN8NyuS5frLYjZdJmXKMki0E9IhOmZzh05Jl1mZSZYCz70us8q6klfWSiaFrwTDSinvWabTlFdKeisuydVp7rHvfo4YBnOoQxkd2Ba7MRjNuNCgZAQ_nsCy70Lo0ZtjH133vwww8ydY81-wUdfmFGxsfnveMroDVv9az0lG4P0ZsKG0je9tW9bhL8cZjzaUiJw8cQ9dM2AffjTjA_Zmj7YZ9obFI3maJZyxjMUHkqgAiN9hNJHj</recordid><startdate>200802</startdate><enddate>200802</enddate><creator>Han, Weixing</creator><creator>Li, Hewang</creator><creator>Villar, Van Anthony M</creator><creator>Pascua, Annabelle M</creator><creator>Dajani, Mustafa I</creator><creator>Wang, Xiaoyang</creator><creator>Natarajan, Aruna</creator><creator>Quinn, Mark T</creator><creator>Felder, Robin A</creator><creator>Jose, Pedro A</creator><creator>Yu, Peiying</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200802</creationdate><title>Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells</title><author>Han, Weixing ; Li, Hewang ; Villar, Van Anthony M ; Pascua, Annabelle M ; Dajani, Mustafa I ; Wang, Xiaoyang ; Natarajan, Aruna ; Quinn, Mark T ; Felder, Robin A ; Jose, Pedro A ; Yu, Peiying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6081-7b34beeb0a9beb54b8a48406129f7c8dabc2daa4043fd30ed55ff087662d54fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acetophenones - pharmacology</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>beta-Cyclodextrins - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood vessels and receptors</topic><topic>Cardiology. Vascular system</topic><topic>Cell Membrane - enzymology</topic><topic>Cholesterol - metabolism</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Fenoldopam - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Immunoblotting</topic><topic>Isoenzymes - genetics</topic><topic>Kidney Tubules, Proximal - cytology</topic><topic>Kidney Tubules, Proximal - enzymology</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - antagonists & inhibitors</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Microdomains - physiology</topic><topic>NADPH Oxidase 2</topic><topic>NADPH Oxidase 4</topic><topic>NADPH Oxidases - antagonists & inhibitors</topic><topic>NADPH Oxidases - genetics</topic><topic>NADPH Oxidases - metabolism</topic><topic>Onium Compounds - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Receptors, Dopamine D1 - agonists</topic><topic>RNA, Messenger - metabolism</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Han, Weixing</creatorcontrib><creatorcontrib>Li, Hewang</creatorcontrib><creatorcontrib>Villar, Van Anthony M</creatorcontrib><creatorcontrib>Pascua, Annabelle M</creatorcontrib><creatorcontrib>Dajani, Mustafa I</creatorcontrib><creatorcontrib>Wang, Xiaoyang</creatorcontrib><creatorcontrib>Natarajan, Aruna</creatorcontrib><creatorcontrib>Quinn, Mark T</creatorcontrib><creatorcontrib>Felder, Robin A</creatorcontrib><creatorcontrib>Jose, Pedro A</creatorcontrib><creatorcontrib>Yu, Peiying</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Weixing</au><au>Li, Hewang</au><au>Villar, Van Anthony M</au><au>Pascua, Annabelle M</au><au>Dajani, Mustafa I</au><au>Wang, Xiaoyang</au><au>Natarajan, Aruna</au><au>Quinn, Mark T</au><au>Felder, Robin A</au><au>Jose, Pedro A</au><au>Yu, Peiying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2008-02</date><risdate>2008</risdate><volume>51</volume><issue>2, Part 2</issue><spage>481</spage><epage>487</epage><pages>481-487</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>Recent studies have indicated the importance of cholesterol-rich membrane lipid rafts (LRs) in oxidative stress-induced signal transduction. Reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases, the major sources of reactive oxygen species, are implicated in cardiovascular diseases, including hypertension. We tested the hypothesis that NADPH oxidase subunits and activity are regulated by LRs in human renal proximal tubule cells. We report that a high proportion of p22 and the small GTPase Rac1 are expressed in LRs in human renal proximal tubule cells. The D1-like receptor agonist, fenoldopam (1 μmol/L per 20 minutes) dispersed Nox subunits within LRs and non-LRs and decreased oxidase activity (30.7±3.3%). In contrast, cholesterol depletion (2% methyl-β-cyclodextrin [βCD]) translocated NADPH oxidase subunits out of LRs and increased oxidase activity (154.0±10.5% versus control, 103.1±3.4%), which was reversed by cholesterol repletion (118.9±9.9%). Moreover, NADPH oxidase activation by βCD (145.5±9.0%; control98.6±1.6%) was also abrogated by the NADPH oxidase inhibitors apocynin (100.4±3.2%) and diphenylene iodonium (9.5±3.3%). Furthermore, βCD-induced reactive oxygen species production was reversed by knocking down either Nox2 (81.0±5.1% versus βCD162.0±2.0%) or Nox4 (108.0±10.8% versus βCD152.0±9.8%). We have demonstrated for the first time that disruption of LRs results in NADPH oxidase activation that is abolished by antioxidants and silencing of Nox2 or Nox4. Therefore, in human renal proximal tubule cells, LRs maintain NADPH oxidase in an inactive state.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>18195159</pmid><doi>10.1161/HYPERTENSIONAHA.107.103275</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 2008-02, Vol.51 (2, Part 2), p.481-487 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_miscellaneous_70237154 |
source | EZB Free E-Journals |
subjects | Acetophenones - pharmacology Arterial hypertension. Arterial hypotension beta-Cyclodextrins - pharmacology Biological and medical sciences Blood and lymphatic vessels Blood vessels and receptors Cardiology. Vascular system Cell Membrane - enzymology Cholesterol - metabolism Dopamine Agonists - pharmacology Enzyme Activation - drug effects Enzyme Inhibitors - pharmacology Fenoldopam - pharmacology Fundamental and applied biological sciences. Psychology Humans Immunoblotting Isoenzymes - genetics Kidney Tubules, Proximal - cytology Kidney Tubules, Proximal - enzymology Medical sciences Membrane Glycoproteins - antagonists & inhibitors Membrane Glycoproteins - genetics Membrane Microdomains - physiology NADPH Oxidase 2 NADPH Oxidase 4 NADPH Oxidases - antagonists & inhibitors NADPH Oxidases - genetics NADPH Oxidases - metabolism Onium Compounds - pharmacology Reactive Oxygen Species - metabolism Receptors, Dopamine D1 - agonists RNA, Messenger - metabolism RNA, Small Interfering - pharmacology Vertebrates: cardiovascular system |
title | Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A58%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipid%20Rafts%20Keep%20NADPH%20Oxidase%20in%20the%20Inactive%20State%20in%20Human%20Renal%20Proximal%20Tubule%20Cells&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Han,%20Weixing&rft.date=2008-02&rft.volume=51&rft.issue=2,%20Part%202&rft.spage=481&rft.epage=487&rft.pages=481-487&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/HYPERTENSIONAHA.107.103275&rft_dat=%3Cproquest_cross%3E70237154%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6081-7b34beeb0a9beb54b8a48406129f7c8dabc2daa4043fd30ed55ff087662d54fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70237154&rft_id=info:pmid/18195159&rfr_iscdi=true |